Destiny Pharma's nasal spray project already delivering "more than hoped for"
News release
by
Destiny Pharma PLC
London, UK
|
May 02, 2023 07:30 AM Eastern Daylight Time
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) CEO Neil Clark speaks to Proactive after releasing fresh data from the update from a research collaboration into a novel biotherapeutic treatment for COVID-19 and influenza. Clark says that the project has already delivered "more than hoped for" and that it will be "really interesting to see where [it] goes next."
Contact Details
Proactive UK Ltd
+44 20 7989 0813
